Technologies
Harnessing Technology for Breakthrough Discoveries
High-Throughput Sequencing-Based High-Throughput Screening (HTS²) is a groundbreaking high-throughput screening method that uses advanced genomics to discover new medicines. This method allows for the large-scale analysis of genes associated with specific diseases, helping us find small molecules that can target these disease-related genes. HTS² connects the pathways of disease response to drug actions, offering a new, efficient way to discover targeted therapies for various diseases. This technology represents a significant step forward in the search for new and effective treatments. By integrating these cutting-edge methods, we offer comprehensive solutions that speed up research and open up exciting new possibilities in the life sciences.
High-throughput, multiplex screening
Ultra-High-Throughput Screening (uHTS) revolutionizes drug discovery by enabling the rapid screening of vast compound libraries. This advanced technology can test millions of potential drug candidates quickly, significantly speeding up the identification of promising therapies. uHTS processes thousands of samples daily, dramatically shortening the time needed to find potential drugs. Utilizing advanced robotics, automated liquid handling, and sophisticated data analysis, uHTS ensures high precision and reproducibility. With many years of industrial experience in this technology, our team is committed to delivering exceptional results. Partner with us and trust in our capabilities and dedication to your success.
Ultra-high-throughput screening
High-dimensional flow cytometry is a powerful technique that measures multiple parameters on individual cells simultaneously. Using fluorescently labeled antibodies and advanced detection systems, it analyzes complex cellular populations to provide detailed insights into cellular functions, phenotypes, and interactions. This technology profiles cellular responses to drug candidates, aiding in understanding their effects on different cell types and states. It is crucial for identifying and validating biomarkers, predicting drug efficacy and safety, and stratifying patient populations in clinical trials. Our experienced team uses the latest high-dimensional flow cytometry instruments and software, ensuring precise and comprehensive data analysis tailored to your research needs.
High-dimensional flow cytometry
We are excited to offer the S-PLEX platform to our partners. S-PLEX is MSD’s groundbreaking ultrasensitive assay technology, designed to revolutionize immunoassay sensitivity. With S-PLEX, we achieve dramatic improvements in the lower limit of detection (LLOD), reducing it by 10- to 1000-fold compared to other methods. Integrating S-PLEX into our workflow allows us to push detection boundaries and attain unparalleled assay sensitivity. Our team has extensive experience in multiplex cytokine detection. Partner with us to harness the transformative power of S-PLEX and elevate your research to new heights.